Androgenetic Alopecia (Male & Female Pattern Hair Loss)
The most common indication for PRP hair treatment. A 2023 meta-analysis of 9 RCTs (238 patients) demonstrated significant increases in hair density at 3 and 6 months compared with placebo. PRP works by delivering concentrated PDGF, VEGF, and EGF directly to miniaturised follicles, stimulating them back into the anagen (growth) phase. We grade the pattern and stage first, using the Norwood scale for men and the Ludwig scale for women, because the stage determines how much benefit is realistically available.
PCOS-Related Hair Thinning
Polycystic ovary syndrome causes hormonal imbalances that accelerate follicular miniaturisation. Dr Nafei's endocrinology background informs our approach to PRP for hair loss in women with hormonal drivers — addressing not just the symptom but the underlying metabolic context. PCOS is one of several hormonal drivers behind female pattern hair loss.
Traction Alopecia
Hair loss caused by prolonged tension from tight hairstyles — particularly common in Afro-textured hair. PRP can stimulate damaged follicles in the early-to-moderate stages before permanent scarring occurs.
Post-Hair Transplant Support
PRP is increasingly used as an adjunct to FUE and FUT hair restoration surgery. Growth factors delivered to the transplant site can support graft survival, reduce inflammation, and accelerate healing.
Telogen Effluvium
Stress-induced or post-illness excessive shedding that shifts a large proportion of follicles into the telogen (resting) phase prematurely. PRP can help accelerate the return to active growth.
The 'No Follicle, No Benefit' Rule
We follow a strict clinical principle: PRP stimulates existing follicles but cannot create new ones where none remain. Every patient undergoes digital trichoscopy to map follicle density and confirm biological capacity for regrowth before treatment begins. If you are still working out which of the types of hair loss applies to you, start with our condition guide rather than a treatment page.